30 closest matches · ranked by relevance
Hidradenitis Suppurativa
Primary: Percentage of Participants Achieving Clinical Response as Measured by Hidradenitis Suppurativa Clinical Response (HiSCR) at Week 12 — 26.1; 59.5; 57.3 Percentage of…
Hidradenitis Suppurativa · Hidradenitis · Acne Inversa
Primary: Change in Disease Severity — 23.3; 17.7 score on a scale — p=0.042
Hidradenitis Suppurativa (HS)
Primary: Percentage of Participants Achieving Hidradenitis Suppurativa Clinical Response (HiSCR) at Week 12 — 26.0; 41.8; 29.8; 21.4 percentage of participants — p==0.003
Hidradenitis Suppurativa
Primary: Change in Microbiome — 5.46; 3.88 colony forming units per ml (CFU/ml)
Hidradenitis Suppurativa (HS)
Primary: Percentage of Participants Achieving Hidradenitis Suppurativa Clinical Response (HiSCR) at Week 12 — 23.8; 38.3 percentage of participants — p=0.018
Hidradenitis Suppurativa
Primary: Percentage of Participants Achieving Clinical Response at Week 16 — 17.6; 9.6; 3.9 percentage of participants — p=0.022
Hidradenitis Suppurativa (HS)
Primary: Percentage of Participants Achieving Hidradenitis Suppurativa Clinical Response (HiSCR) at Week 12 — 27.6; 58.9; 36.8; 17.1 percentage of participants — p=<0.001
Hidradenitis Suppurativa
Primary: Percentage of Participants Achieving Hidradenitis Suppurativa Clinical Response (HiSCR) at Week 16 — 31.8; 48.9 percentage of participants — p=0.189
Hidradenitis Suppurativa · Hidradenitis
Primary: Ease of Use Day 21 vs Day 0 — 6.47; 0.6 score on a scale
Hidradenitis Suppurativa
Primary: Percentage of Participants Achieving Hidradenitis Suppurativa Clinical Response (HiSCR) at Week 16 — 38.7; 50.8; 45.0 percentage of participants — p== 0.166
Hidradenitis Suppurativa · Surgical Wound
Primary: Wound QOL Survey Score Over Time — 1.14; 0.94; 0.77; 0.66 score on a scale
Hidradenitis Suppurativa
Primary: Period A (DB Period): Percentage of Biologic and Small Molecule Immunosuppressive-Naïve Participants Who Achieved Hidradenitis Suppurativa Clinical Response (HiSCR50) at…
Hidradenitis Suppurativa (HS)
Primary: Percentage of Participants Achieving Hidradenitis Suppurativa Clinical Response (HiSCR) at Week 12 — 34.0; 47.6 percentage of participants — p==0.049
Hidradenitis Suppurativa
Primary: Change From Baseline in Abscess and Inflammatory Nodule (AN) Count at Week 12 — -2.93; -5.94 AN count — p=>0.999
Hidradenitis Suppurativa
Primary: Dermatology Life Quality Index (DLQI) Scores — 15.5; 12.5 score on a scale
Hidradenitis Suppurativa
Primary: Percentage of Participants in the EW/EW/EW, EW/EOW/EW, and EW/PBO/EW Analysis Populations Achieving Clinical Response Per Hidradenitis Suppurativa Clinical Response…
Hidradenitis Suppurativa
Primary: Percentage of Participants Achieving Clinical Response as Measured by Hidradenitis Suppurativa Clinical Response 50 (HiSCR50) at Week 16 — 32.2; 53.8; 52.0 percentage of…
Hidradenitis Suppurativa
Primary: Percentage of Participants Achieving Clinical Response as Measured by Hidradenitis Suppurativa Clinical Response 50 (HiSCR50) at Week 16 — 28.7; 45.3; 47.8 percentage of…
Hidradenitis Suppurativa
Primary: Percentage of Participants With Hidradenitis Suppurativa Clinical Response (HiSCR50) — 45.0; 41.8; 33.7 Percentage of participants — p=0.0070
Hidradenitis Suppurativa
Primary: Number of Participants With Treatment-emergent Adverse Events (TEAEs) — 7 Participants
Hidradenitis Suppurativa
Primary: Number of Days to Lesion Resolution in Combined Treatment Arms Compared to the Placebo Arm. — 10.8; 10.9; 9.35 Days — p=0.77
Hidradenitis Suppurativa
Primary: Part A: Number of Participants Who Achieved Hidradenitis Suppurativa Clinical Response 75 (HiSCR75) at Week 12 — 12 Participants
Hidradenitis Suppurativa
Primary: Part 1 - Percent Change From Baseline in Draining Fistula/Tunnel (dT) Count at Week 8 — -21.5; -41.9; -39.3; -25.8 Percentage change — p=0.697
Hidradenitis Suppurativa
Primary: Visits to High-cost Care Settings [ Time Frame: 1.5 Months ] — 0; 0 Participants
Hidradenitis Suppurativa (HS)
Primary: Percent Change in Wound Size — 57.2 percentage change in wound size
Hidradenitis Suppurativa
Primary: Percentage of Participants Achieving Hidradenitis Suppurativa Clinical Response (HiSCR) at Week 12 — 86.7 percentage of participants
Acne Inversa
Primary: Percentage of Participants Achieving Hidradenitis Suppurativa Clinical Response (HiSCR) at Week 16- Minimum Risk (MR) [Full Analysis Set (FAS), Non-responder Imputation…
Hidradenitis Suppurativa
Primary: Percent Change From Baseline in Total Abscess and Inflammatory Nodule Count at Week 12 — -34.7; -38.8 percent change
Hidradenitis Suppurativa
Primary: Percentage of Participants With Hidradenitis Suppurativa Clinical Response (HiSCR50) — 42.3; 46.1; 31.2 Percentage of Participants — p=0.0149
Hidradenitis Suppurativa (HS)
Primary: Number of Patients With Hidradenitis Suppurativa Clinical Response (HiSCR) Determined at Week 16 — 16; 12; 17; 12 Participants